I-Human CYP2C9 kunye ne-VKORC1 Gene Polymorphism

Inkcazo emfutshane:

Le khithi iyasebenza ekufumaneni i-polymorphism ye-CYP2C9*3 (rs1057910, 1075A>C) kunye ne-VKORC1 (rs9923231, -1639G>A) kwi-genomic DNA yeesampuli zegazi lomntu.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Igama lemveliso

I-HWTS-GE014A-Human CYP2C9 kunye ne-VKORC1 Gene Polymorphism Detection Kit (i-Fluorescence PCR)

Isatifikethi

I-CE/TFDA

I-Epidemiology

I-Warfarin sisibulali-gazi esisetyenziswa kakhulu kunyango ngoku, esenzelwe kakhulu ukuthintela nokunyanga izifo ze-thromboembolic. Nangona kunjalo, i-warfarin inonyango olulinganiselweyo kwaye yahluka kakhulu phakathi kweentlanga ezahlukeneyo kunye nabantu ngabanye. Izibalo zibonise ukuba umahluko wedosi ezinzileyo kubantu abahlukeneyo unokuba ngaphezu kwezihlandlo ezingama-20. Ukopha okungalunganga kwenzeka kwi-15.2% yezigulane ezithatha i-warfarin minyaka le, apho i-3.5% yazo ifumana ukopha okubulalayo. Izifundo ze-Pharmacogenomic zibonise ukuba i-polymorphism ye-genetic ye-enzyme ejoliswe kwi-VKORC1 kunye ne-enzyme ye-metabolic CYP2C9 ye-warfarin yinto ebalulekileyo echaphazela umahluko kwidosi ye-warfarin. I-Warfarin sisithinteli esithile se-vitamin K epoxide reductase (VKORC1), kwaye ngaloo ndlela ithintela ukwenziwa kwezinto ezivala igazi ezibandakanya i-vitamin K kwaye ibonelela ngokuthintela ukubola kwegazi. Inani elikhulu lezifundo libonise ukuba i-polymorphism ye-gene ye-VKORC1 promoter yeyona nto ibalulekileyo echaphazela umahluko wohlanga kunye nomntu ngamnye kwidosi efunekayo ye-warfarin. I-Warfarin iguqulwa yi-CYP2C9, kwaye iinguqu zayo zicotha kakhulu imetabolism ye-warfarin. Abantu abasebenzisa i-warfarin banomngcipheko ophezulu (ophindwe kabini ukuya kathathu) wokopha kwinqanaba lokuqala lokusetyenziswa.

Itshaneli

I-FAM I-VKORC1 (-1639G>A)
CY5 I-CYP2C9*3
I-VIC/HEX IC

Iiparameters zobugcisa

Indawo yokugcina izinto Ulwelo: ≤-18℃
Beka ubomi kwishelufa Iinyanga ezili-12
Uhlobo lweSibonelelo Igazi elitsha elichasene nokugaywa kwegazi yi-EDTA
CV ≤5.0%
I-LoD 1.0ng/μL
Ukuchaneka Akukho reactivity edibeneyo kunye nolandelelwano oluhambelanayo kakhulu lwe-genome yomntu (i-human CYP2C19 gene, i-human RPN2 gene); ukuguqulwa kwe-CYP2C9*13 kunye ne-VKORC1 (3730G>A) ngaphandle koluhlu lokufumanisa lwale kit.
Izixhobo Ezisebenzayo Iinkqubo ze-PCR ze-Applied Biosystems 7500 Real-Time

Iinkqubo ze-PCR eziSebenzisiweyo ze-7500 ezikhawulezayo zeXesha langempela

Iinkqubo ze-PCR zeQuantStudio®5 zeXesha langempela

Iinkqubo ze-PCR ze-SLAN-96P zeXesha langempela

Inkqubo ye-PCR yeLightCycler®480 yeXesha langempela

Inkqubo yokuHlola i-PCR yeLineGene 9600 Plus ngexesha langempela

I-MA-6000 Real-Time Quantitative Thermal Cycler

Inkqubo ye-PCR ye-BioRad CFX96 yeXesha langempela

Inkqubo ye-PCR ye-BioRad CFX Opus 96 yeXesha langempela

Ukuhamba komsebenzi

I-reagent yokukhutshelwa ecetyiswayo: I-Macro & Micro-Test Viral DNA/RNA Kit (HWTS-3001, HWTS-3004-32, HWTS-3004-48, HWTS-3004-96) kunye ne-Macro & Micro-Test Automatic Nucleic Acid Extractor (HWTS-3006).


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha uze uwuthumele kuthi